The unified social credit code/registration number of Yantai Dongcheng Pharmaceutical Group Co., Ltd. is 9 1370000705877283D, and the enterprise is in the opening state.
The business scope of Yantai Dongcheng Pharmaceutical Group Co., Ltd. is: production, processing and sales of raw materials (heparin sodium, heparin calcium, chondroitin sulfate sodium, chondroitin sulfate sodium (for injection), nadroparin calcium, enoxaparin sodium and daparine sodium); Production, processing and sales of chondroitin sulfate, collagen, hyaluronic acid, cytochrome C (freeze-dried), shark bone powder and glucosamine hydrochloride; Import and export of goods and technologies; Research and development of pharmaceutical technology and products, transfer of achievements, related technical consultation and services. (Projects subject to approval according to law can only be operated after approval by relevant departments, and the validity period is subject to the license). In Shandong province, the total registered capital of companies with similar business scope is160 million yuan, and the main capital is concentrated in three enterprises with a scale of more than 50 million. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
Yantai Dongcheng Pharmaceutical Group Co., Ltd. invested in 9 companies and 0 branches.
View more information and information of Yantai Dongcheng Pharmaceutical Group Co., Ltd. through Baidu Enterprise Credit.